300 related articles for article (PubMed ID: 33247623)
1. Brain volumetric deficits in MAPT mutation carriers: a multisite study.
Chu SA; Flagan TM; Staffaroni AM; Jiskoot LC; Deng J; Spina S; Zhang L; Sturm VE; Yokoyama JS; Seeley WW; Papma JM; Geschwind DH; Rosen HJ; Boeve BF; Boxer AL; Heuer HW; Forsberg LK; Brushaber DE; Grossman M; Coppola G; Dickerson BC; Bordelon YM; Faber K; Feldman HH; Fields JA; Fong JC; Foroud T; Gavrilova RH; Ghoshal N; Graff-Radford NR; Hsiung GR; Huey ED; Irwin DJ; Kantarci K; Kaufer DI; Karydas AM; Knopman DS; Kornak J; Kramer JH; Kukull WA; Lapid MI; Litvan I; Mackenzie IRA; Mendez MF; Miller BL; Onyike CU; Pantelyat AY; Rademakers R; Marisa Ramos E; Roberson ED; Carmela Tartaglia M; Tatton NA; Toga AW; Vetor A; Weintraub S; Wong B; Wszolek ZK; ; Van Swieten JC; Lee SE
Ann Clin Transl Neurol; 2021 Jan; 8(1):95-110. PubMed ID: 33247623
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia.
Jiskoot LC; Panman JL; Meeter LH; Dopper EGP; Donker Kaat L; Franzen S; van der Ende EL; van Minkelen R; Rombouts SARB; Papma JM; van Swieten JC
Brain; 2019 Jan; 142(1):193-208. PubMed ID: 30508042
[TBL] [Abstract][Full Text] [Related]
3. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study.
Panman JL; Jiskoot LC; Bouts MJRJ; Meeter LHH; van der Ende EL; Poos JM; Feis RA; Kievit AJA; van Minkelen R; Dopper EGP; Rombouts SARB; van Swieten JC; Papma JM
Neurobiol Aging; 2019 Apr; 76():115-124. PubMed ID: 30711674
[TBL] [Abstract][Full Text] [Related]
4. Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.
Staffaroni AM; Goh SM; Cobigo Y; Ong E; Lee SE; Casaletto KB; Wolf A; Forsberg LK; Ghoshal N; Graff-Radford NR; Grossman M; Heuer HW; Hsiung GR; Kantarci K; Knopman DS; Kremers WK; Mackenzie IR; Miller BL; Pedraza O; Rascovsky K; Tartaglia MC; Wszolek ZK; Kramer JH; Kornak J; Boeve BF; Boxer AL; Rosen HJ;
JAMA Netw Open; 2020 Oct; 3(10):e2022847. PubMed ID: 33112398
[TBL] [Abstract][Full Text] [Related]
5. Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study.
Cash DM; Bocchetta M; Thomas DL; Dick KM; van Swieten JC; Borroni B; Galimberti D; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni GB; Laforce R; Finger E; de Mendonça A; Sorbi S; Rossor MN; Ourselin S; Rohrer JD;
Neurobiol Aging; 2018 Feb; 62():191-196. PubMed ID: 29172163
[TBL] [Abstract][Full Text] [Related]
6. [
Wolters EE; Papma JM; Verfaillie SCJ; Visser D; Weltings E; Groot C; van der Ende EL; Giannini LAA; Tuncel H; Timmers T; Boellaard R; Yaqub M; van Assema DME; Kuijper DA; Segbers M; Rozemuller AJM; Barkhof F; Windhorst AD; van der Flier WM; Pijnenburg YAL; Scheltens P; van Berckel BNM; van Swieten JC; Ossenkoppele R; Seelaar H
Neurology; 2021 Sep; 97(10):e1017-e1030. PubMed ID: 34210823
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Brain Atrophy Rates in Presymptomatic Carriers of Genetic Frontotemporal Dementia.
Poos JM; Grandpierre LDM; van der Ende EL; Panman JL; Papma JM; Seelaar H; van den Berg E; van 't Klooster R; Bron E; Steketee R; Vernooij MW; Pijnenburg YAL; Rombouts SARB; van Swieten J; Jiskoot LC
Neurology; 2022 Dec; 99(24):e2661-e2671. PubMed ID: 36288997
[TBL] [Abstract][Full Text] [Related]
8. Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum.
Zhang L; Flagan TM; Häkkinen S; Chu SA; Brown JA; Lee AJ; Pasquini L; Mandelli ML; Gorno-Tempini ML; Sturm VE; Yokoyama JS; Appleby BS; Cobigo Y; Dickerson BC; Domoto-Reilly K; Geschwind DH; Ghoshal N; Graff-Radford NR; Grossman M; Hsiung GR; Huey ED; Kantarci K; Lario Lago A; Litvan I; Mackenzie IR; Mendez MF; Onyike CU; Ramos EM; Roberson ED; Tartaglia MC; Toga AW; Weintraub S; Wszolek ZK; Forsberg LK; Heuer HW; Boeve BF; Boxer AL; Rosen HJ; Miller BL; Seeley WW; Lee SE;
Ann Neurol; 2023 Oct; 94(4):632-646. PubMed ID: 37431188
[TBL] [Abstract][Full Text] [Related]
9. Characterizing the Clinical Features and Atrophy Patterns of
Young AL; Bocchetta M; Russell LL; Convery RS; Peakman G; Todd E; Cash DM; Greaves CV; van Swieten J; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Sorbi S; Williams SCR; Alexander DC; Rohrer JD;
Neurology; 2021 Aug; 97(9):e941-e952. PubMed ID: 34158384
[TBL] [Abstract][Full Text] [Related]
10. Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales.
Fumagalli GG; Basilico P; Arighi A; Bocchetta M; Dick KM; Cash DM; Harding S; Mercurio M; Fenoglio C; Pietroboni AM; Ghezzi L; van Swieten J; Borroni B; de Mendonça A; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni GB; Laforce R; Finger E; Sorbi S; Scarpini E; Rohrer JD; Galimberti D;
Alzheimers Res Ther; 2018 May; 10(1):46. PubMed ID: 29793546
[TBL] [Abstract][Full Text] [Related]
11. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study.
Mutsaerts HJMM; Mirza SS; Petr J; Thomas DL; Cash DM; Bocchetta M; de Vita E; Metcalfe AWS; Shirzadi Z; Robertson AD; Tartaglia MC; Mitchell SB; Black SE; Freedman M; Tang-Wai D; Keren R; Rogaeva E; van Swieten J; Laforce R; Tagliavini F; Borroni B; Galimberti D; Rowe JB; Graff C; Frisoni GB; Finger E; Sorbi S; de Mendonça A; Rohrer JD; MacIntosh BJ; Masellis M;
Brain; 2019 Apr; 142(4):1108-1120. PubMed ID: 30847466
[TBL] [Abstract][Full Text] [Related]
12. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.
Rohrer JD; Nicholas JM; Cash DM; van Swieten J; Dopper E; Jiskoot L; van Minkelen R; Rombouts SA; Cardoso MJ; Clegg S; Espak M; Mead S; Thomas DL; De Vita E; Masellis M; Black SE; Freedman M; Keren R; MacIntosh BJ; Rogaeva E; Tang-Wai D; Tartaglia MC; Laforce R; Tagliavini F; Tiraboschi P; Redaelli V; Prioni S; Grisoli M; Borroni B; Padovani A; Galimberti D; Scarpini E; Arighi A; Fumagalli G; Rowe JB; Coyle-Gilchrist I; Graff C; Fallström M; Jelic V; Ståhlbom AK; Andersson C; Thonberg H; Lilius L; Frisoni GB; Pievani M; Bocchetta M; Benussi L; Ghidoni R; Finger E; Sorbi S; Nacmias B; Lombardi G; Polito C; Warren JD; Ourselin S; Fox NC; Rossor MN; Binetti G
Lancet Neurol; 2015 Mar; 14(3):253-62. PubMed ID: 25662776
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia.
Dopper EG; Rombouts SA; Jiskoot LC; den Heijer T; de Graaf JR; de Koning I; Hammerschlag AR; Seelaar H; Seeley WW; Veer IM; van Buchem MA; Rizzu P; van Swieten JC
Neurology; 2014 Jul; 83(2):e19-26. PubMed ID: 25002573
[TBL] [Abstract][Full Text] [Related]
14. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration.
Giannini LA; Mol MO; Rajicic A; van Buuren R; Sarkar L; Arezoumandan S; Ohm DT; Irwin DJ; Rozemuller AJ; ; van Swieten JC; Seelaar H
Acta Neuropathol Commun; 2023 Aug; 11(1):126. PubMed ID: 37533060
[TBL] [Abstract][Full Text] [Related]
15. Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.
Premi E; Grassi M; van Swieten J; Galimberti D; Graff C; Masellis M; Tartaglia C; Tagliavini F; Rowe JB; Laforce R; Finger E; Frisoni GB; de Mendonça A; Sorbi S; Gazzina S; Cosseddu M; Archetti S; Gasparotti R; Manes M; Alberici A; Cardoso MJ; Bocchetta M; Cash DM; Ourselin S; Padovani A; Rohrer JD; Borroni B;
Brain; 2017 Jun; 140(6):1784-1791. PubMed ID: 28460069
[TBL] [Abstract][Full Text] [Related]
16. Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers.
Chen Q; Boeve BF; Schwarz CG; Reid R; Tosakulwong N; Lesnick TG; Bove J; Brannelly P; Brushaber D; Coppola G; Dheel C; Dickerson BC; Dickinson S; Faber K; Fields J; Fong J; Foroud T; Forsberg L; Gavrilova RH; Gearhart D; Ghoshal N; Goldman J; Graff-Radford J; Graff-Radford NR; Grossman M; Haley D; Heuer HW; Hsiung GR; Huey E; Irwin DJ; Jack CR; Jones DT; Jones L; Karydas AM; Knopman DS; Kornak J; Kramer J; Kremers W; Kukull WA; Lapid M; Lucente D; Lungu C; Mackenzie IRA; Manoochehri M; McGinnis S; Miller BL; Pearlman R; Petrucelli L; Potter M; Rademakers R; Ramos EM; Rankin KP; Rascovsky K; Sengdy P; Shaw L; Syrjanen J; Tatton N; Taylor J; Toga AW; Trojanowski J; Weintraub S; Wong B; Boxer AL; Rosen H; Wszolek Z; Kantarci K;
Neurobiol Aging; 2019 Nov; 83():54-62. PubMed ID: 31585367
[TBL] [Abstract][Full Text] [Related]
17. A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort.
Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Greaves C; Russell LL; Clarke MTM; Peakman G; van Swieten J; Jiskoot L; Moreno F; Barandiaran M; Sanchez-Valle R; Borroni B; Laforce R; Doré MC; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Karnath HO; Vandenberghe R; de Mendonça A; Maruta C; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Warren JD; Rohrer JD;
Appl Neuropsychol Adult; 2022; 29(1):112-119. PubMed ID: 32024404
[TBL] [Abstract][Full Text] [Related]
18. Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.
Domínguez-Vivero C; Wu L; Lee S; Manoochehri M; Cines S; Brickman AM; Rizvi B; Chesebro A; Gazes Y; Fallon E; Lynch T; Heidebrink JL; Paulson H; Goldman JS; Huey E; Cosentino S
J Alzheimers Dis; 2020; 75(2):595-606. PubMed ID: 32310161
[TBL] [Abstract][Full Text] [Related]
19. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC
Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986
[TBL] [Abstract][Full Text] [Related]
20. 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.
Wu L; Liu J; Feng X; Dong J; Qin W; Liu Y; Wang J; Lu J; Chen K; Wang Y; Jia J
J Alzheimers Dis; 2018; 61(2):613-618. PubMed ID: 29226866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
